Cart
sales@molnova.com
Lenacapavir
CAS No. 2189684-44-2
Lenacapavir ( GS-6207 )
Catalog No. M26233 CAS No. 2189684-44-2
Lenacapavir is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 621 | Get Quote |
|
| 10MG | 1017 | Get Quote |
|
| 25MG | 1503 | Get Quote |
|
| 50MG | 2025 | Get Quote |
|
| 100MG | 2673 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameLenacapavir
-
NoteResearch use only, not for human use.
-
Brief DescriptionLenacapavir is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells.
-
DescriptionLenacapavir is a potent capsid-targeting inhibitor of HIV replication. Lenacapavir shows anti-HIV activity with an EC50 of 100 pM in MT-4 cells.(In Vitro):Lenacapavir displays a mean EC50 of 50 pM (20-160 pM) against 23 HIV-1 clinical isolates from different subtypes in peripheral blood mononuclear cells. Lenacapavir shows sub-nanomolar potency in target cells with EC50 of 23 pM, in a full-cycle assay with EC50 of 25 pM and in producer cells with EC50 of 439 pM.
-
SynonymsGS-6207
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2189684-44-2
-
Formula Weight968.3
-
Molecular FormulaC39H32ClF10N7O5S2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES[H][C@]12C[C@@]1([H])C(F)(F)c1c2c(nn1CC(=O)N[C@@H](Cc1cc(F)cc(F)c1)c1nc(ccc1-c1ccc(Cl)c2c(NS(C)(=O)=O)nn(CC(F)(F)F)c12)C#CC(C)(C)S(C)(=O)=O)C(F)(F)F
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Tagliabue A, Rappuoli R. Vaccine adjuvants:the dream becomes real. Hum Vaccin. 2008 Sep-Oct;4(5):347-9.
molnova catalog
related products
-
Tricine
Tricine can clearly visualize tumors, may as melanoma imaging agents. Using the combination of tricine and a phosphine ligand, HYNIC-derivatized peptides or other small molecules can be labeled with 99mTc in high specific activity and with high stability for potential use as radiopharmaceuticals.
-
BOS-318
BOS-318 is a Furin inhibitor with slowly dissociating, highly selective, and cell-pemeable characteristcs.
-
Azosemide
Azosemide is a potent NKCC1 inhibitor (IC50s: 0.246?μM and 0.197?μM for hNKCC1A and NKCC1B).
